INSULET CORP 4
4 · INSULET CORP · Filed Dec 3, 2014
Insider Transaction Report
Form 4
INSULET CORPPODD
LIAMOS CHARLES T
Director
Transactions
- Exercise/Conversion
Common Stock
2014-12-01$15.82/sh+4,000$63,280→ 104,733 total - Sale
Common Stock
2014-12-01$45.67/sh−4,000$182,680→ 100,733 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2014-12-01−4,000→ 34,000 totalExercise: $15.82Exp: 2021-01-10→ Common Stock (4,000 underlying)
Footnotes (5)
- [F1]Includes 16,000 restricted stock units granted on April 1, 2012, which vest one-half of the total units on April 1, 2015 and one-half of the total units on April 1, 2016; 22,500 restricted stock units granted on March 1, 2013, which vest one-third of the total units on March 1, 2015, one-third of the total units on March 1, 2016 and one-third of the total units on March 1, 2017; 22,000 performance share units granted on March 1, 2013, which vest one-half of the total units on March 1, 2015 and one-half of the total units on March 1, 2016; and 4,000 restricted stock units granted on June 2, 2014, which vest one-half of the total units on April 30, 2015, one-quarter of the total units on April 30, 2016 and one-quarter of the total units on April 30, 2017. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
- [F2]Includes an aggregate of 1,166 shares acquired under the Insulet Corporation Amended and Restated 2007 Employee Stock Purchase Plan on the following dates: 357 shares acquired on June 29, 2012; 360 shares acquired on December 31, 2012; 243 shares acquired on June 28, 2013; and 206 shares acquired on December 31, 2013.
- [F3]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2014.
- [F4]The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $45.14 to $46.16. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full informaiton regarding the number of shares sold at each separate price.
- [F5]This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.